Burak Sakar

972 total citations
35 papers, 771 citations indexed

About

Burak Sakar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Burak Sakar has authored 35 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Burak Sakar's work include Gastric Cancer Management and Outcomes (9 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Colorectal and Anal Carcinomas (5 papers). Burak Sakar is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Colorectal and Anal Carcinomas (5 papers). Burak Sakar collaborates with scholars based in Türkiye, United States and India. Burak Sakar's co-authors include Nuri Faruk Aykan, Zeki Üstüner, Erkan Topuz, Sezer Sağlam, Mert Başaran, Faruk Taş, Süleyman Alıcı, Yeşim Eralp, Hakan Çamlıca and Esra Kaytan and has published in prestigious journals such as Journal of Clinical Oncology, Biomedicine & Pharmacotherapy and World Journal of Surgery.

In The Last Decade

Burak Sakar

34 papers receiving 745 citations

Peers

Burak Sakar

ONCOL

SURGE

PRM

EPIDE

Zeki Üstüner Türkiye

Yoshinori Munemoto Japan

Soichiro Takai Japan

C. Bokemeyer Germany

Atsushi Oyama Japan

Masahito Tanimizu Japan

Atif Hussein United States

Jeng‐Kae Jiang Taiwan

Işıl Somali Türkiye

Metin Özkan Türkiye

Zeki Üstüner Türkiye

Burak Sakar

219 ×0.6

ONCOL

121 ×0.5

SURGE

124 ×0.6

PRM

86 ×0.8

EPIDE

115 ×1.1

Citations per year, relative to Burak Sakar Burak Sakar (= 1×) peers Zeki Üstüner

Countries citing papers authored by Burak Sakar

Since Specialization

Citations

This map shows the geographic impact of Burak Sakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burak Sakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burak Sakar more than expected).

Fields of papers citing papers by Burak Sakar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burak Sakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burak Sakar. The network helps show where Burak Sakar may publish in the future.

Co-authorship network of co-authors of Burak Sakar

This figure shows the co-authorship network connecting the top 25 collaborators of Burak Sakar. A scholar is included among the top collaborators of Burak Sakar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burak Sakar. Burak Sakar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karabulut, Senem, et al.. (2022). Evaluation of Prognostic Factors and Trastuzumab-based Treatments in HER2/Neu-positive Metastatic Gastric Cancer. Journal of College of Physicians And Surgeons Pakistan. 32(8). 1014–1019. 2 indexed citations

Sağlam, Esra, Emre Balık, Sezer Sağlam, et al.. (2014). Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study. Journal of Cancer Research and Clinical Oncology. 141(2). 361–367. 6 indexed citations

Taş, Faruk, Senem Karabulut, Rümeysa Çiftçi, et al.. (2014). Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy. Cancer Chemotherapy and Pharmacology. 73(6). 1163–1171. 47 indexed citations

Aykan, Nuri Faruk, İbrahim Yıldız, Fatma Şen, et al.. (2013). Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy. Medical Oncology. 30(3). 679–679. 23 indexed citations

Keskın, Serkan, İsmail Yıldız, Fatma Şen, et al.. (2012). Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC). Clinical & Translational Oncology. 15(5). 403–408. 8 indexed citations

Topuz, Erkan, Duygu Derin, Gülbeyaz Can, et al.. (2008). Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer. Investigational New Drugs. 26(6). 567–572. 39 indexed citations

Başaran, Mert, Sezer Sağlam, Levent Eralp, et al.. (2007). A Phase II Study of Cisplatin, Ifosfamide and Epirubicin Combination Chemotherapy in Adults with Nonmetastatic and Extremity Osteosarcomas. Oncology. 72(3-4). 255–260. 24 indexed citations

Sakar, Burak, Mert Başaran, Andaç Argon, et al.. (2007). XELOX Followed by XELIRI or the Reverse Sequence in Advanced Colorectal Cancer. Oncology. 73(5-6). 298–304. 7 indexed citations

Taş, Faruk, Zeki Üstüner, Gülbeyaz Can, et al.. (2005). The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncologica. 44(2). 161–167. 66 indexed citations

10.

Üstüner, Zeki, Mert Başaran, Talat Kırış, et al.. (2004). Skull Base Plasmacytoma in a Patient with Light Chain Myeloma. Skull base. 13(3). 167–172. 33 indexed citations

11.

Sakar, Burak, Hakan Karagöl, Mahmut Gümüş, et al.. (2004). Timing of Death From Tumor Recurrence After Curative Gastrectomy for Gastric Cancer. American Journal of Clinical Oncology. 27(2). 205–209. 45 indexed citations

12.

Sakar, Burak, Zeki Üstüner, Hakan Karagöl, et al.. (2004). Prognostic Features and Survival of Inoperable Hepatocellular Carcinoma in Turkish Patients With Cirrhosis. American Journal of Clinical Oncology. 27(5). 489–493. 17 indexed citations

13.

Başaran, Mert, et al.. (2003). Adult primary extragonadal germ cell tumors: Treatment results and long‐term follow‐up. Medical and Pediatric Oncology. 41(1). 49–53. 3 indexed citations

14.

Eralp, Yeşim, et al.. (2003). Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix. International Journal of Gynecological Cancer. 13(4). 497–504. 25 indexed citations

15.

Alıcı, Süleyman, et al.. (2003). Colorectal Cancer in Young Patients: Characteristics and Outcome. The Tohoku Journal of Experimental Medicine. 199(2). 85–93. 84 indexed citations

16.

Akın, Mehmet, et al.. (2003). Tamoxifen and Gallstone Formation in Postmenopausal Breast Cancer Patients: Retrospective Cohort Study. World Journal of Surgery. 27(4). 395–399. 12 indexed citations

17.

Başaran, Mert, Sevil Bavbek, İbrahim Güllü, et al.. (2002). A Phase II Study of Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent or Metastatic Head and Neck Cancer. Journal of Chemotherapy. 14(2). 207–213. 22 indexed citations

18.

Taş, Faruk, Yeşim Eralp, Mert Başaran, et al.. (2002). Anemia in Oncology Practice. American Journal of Clinical Oncology. 25(4). 371–379. 89 indexed citations

19.

Topuz, Erkan, Mert Başaran, Adnan Aydıner, et al.. (2002). Adjuvant Intraperitoneal Chemotherapy With Cisplatinum, Mitoxantrone, 5-Fluorouracil, and Calcium Folinate in Patients With Gastric Cancer. American Journal of Clinical Oncology. 25(6). 619–624. 18 indexed citations

20.

Başaran, Mert, Burak Sakar, Yeşim Eralp, et al.. (2001). Treatment of Aggressive Non-Hodgkin’s Lymphoma With Dose-Intensified Epirubicin in Combination of Cyclophosphamide, Vincristine, and Prednisone (CEOP-100). American Journal of Clinical Oncology. 24(6). 570–575. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact